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 Spinal cord injury (SCI) has presented itself as a multifaceted pathology that is 
largely inhibitory to regeneration, and therefore to functional recovery, even though spinal cord 
neurons have been found to be innately regenerative. Thus, having identified the key players in 
the inhibition of this innate regeneration, SCI researchers have focused on two major types of 
approaches: (1) blocking inhibitory cues and (2) promoting innate regeneration. Schwann cells 
(SCs) have long been shown to promote and enhance functional recovery after SCI through 
providing supplemental myelination and trophic and tropic factors to regenerating axons, though 
singular approaches rarely address the complex SCI pathology. Guidance channels and scaffolds 
have been shown to provide physical support and directional cues to regeneration axons. 
Therefore, a combinatorial approach in which SCs migrate into and throughout a guidance 
scaffold would be an ideal research focus for treating SCI. However, cell migration into guidance 
scaffolds has been shown to be problematic. This study attempts to assess and improve two- and 
three-dimensional SC migration on electrospun scaffolds. Additionally, we evaluate the ability of 
SCs, seeded on Matrigel-coated electrospun scaffolds, to improve functional recovery in rats 
with completely transected spinal cords. 
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INTRODUCTION 
 
 Originally viewed as inflexible to and unsupportive of regeneration, the adult 
central nervous system’s reputation has been upended in the past century, lending itself to a host 
of clinically-significant alterations. Since this transformation, spinal cord injury treatment and 
the approach to improving it has progressed aggressively. Following findings that the central 
nervous system (CNS) neurons can regenerate (Aguayo, 1981) and that local axonal sprouting 
was a probable mechanism for regeneration (Selzer, 1978; Raisman, 1978), spinal cord injury 
(SCI) research began to focus on altering the injury environment to facilitate this axonal 
regeneration. However, these regeneration attempts were frequently deterred by the multitude of 
inhibitory cell types and molecules present at the SCI site (Fawcett and Asher, 1999). Promising 
strategies have thus fallen under two categories: (1) Those that block cues that inhibit 
regeneration and (2) those that provide or enhance growth-promoting cues that allow 
regeneration to overcome inhibitory cues (Fouad et al., 2005). Though many desirable endpoints 
of CNS repair, such as full, functional control of locomotion and of micturition, have not been 
reached consistently in humans or in animal models, CNS repair strategies after SCI have shown 
significant improvement and potential. The transplantation of Schwann cells (SCs) into the SCI 
site to aid recovery has been established as an effective strategy, comprising elements that block 
regeneration inhibition and strongly enhance axonal health and regeneration (Duncan, Aguayo, 
Bunge, Wood, 1981; Bunge, 2008). However, the inability of SCs to address all SCI deficiencies 
has led to the call for combination strategies. Recently, the use of electrospinning to bioengineer 
scaffolds for the guidance and support of both implanted and native cells has been shown to be 
used, alone and in combination, in central nerve regeneration attempts (Tabesh et al., 2009). This 
paper will briefly overview the cellular response with attention to the ability of each majorly 
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involved cell type to aid SCI recovery, review the strengths and weaknesses of the most 
popularly published SCI recovery strategies, present Schwann cells and bioengineered axonal 
guidance scaffolds as promising strategies to attenuate this inhibition, and review the results of a 
project that evaluated their combination as a way to improve SCI recovery.  
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Chapter 1: 
 
The Cellular Response to SCI 
 
A progressive phenomenon, SCI pathophysiology arguably comprises different stages. 
After insult, the CNS incurs primary, secondary, and tertiary lesions. Primary lesions, such as 
compressed or cut axons, are normally direct effects of the damaging agent (ex. physical impact 
or toxin). These injurious physiological changes usually lead to secondary lesions, including 
ischemia, axonal degradation, anoxia, and free radical formation, which then cause tertiary 
lesions, including immune cell recruitment, glial scar formation, and neuronal and glial cell death 
(Du et al., 2011; Onifer et al., 2007; Zhilai et al., 2011; Zong et al., 2011). 
Upon insult, various cell types endogenous to the CNS undergo major modifications, 
while cell types exogenous to the CNS migrate into the injury site milieu. Endogenous cell types 
that undergo major alterations include astrocytes, oligodendrocytes, microglia/macrophages, 
oligodendrocyte precursors, and multipotential progenitor cells. Cells that migrate into the CNS 
after injury include Schwann cells (SCs), meningeal cells, and monocytes/macrophages. This 
section will briefly summarize actions of the some of these cell types in the context of 
regeneration and repair, focusing finally on SCs and why they are arguably the most conducive 
to repair and regeneration. 
 
Neurons 
Following the destruction of axonal segments, both the proximal and distal ends 
degenerate. The distal ends of affected neurons usually undergo complete structural 
disintegration and chemical degradation in which the axolemma beads and swells and 
microtubules, neurofilaments and other cytoskeleton components undergo granular disintegration 
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(Vargas and Barres, 2007); this is termed Wallerian degeneration (Lavdas et al., 
2008).Complementary to this process, central chromatolysis, which was first described by the 
disintegration of Nissl substance and has come to define the general degenerative response after 
axonal injury, occurs in the proximal end of affected neurons (Tellez et al., 1987).  The 
corresponding myelin sheath, whose integrity depends both on the health of the providing 
oligodendrocyte and on the structure of the axon it is enveloping, undergoes a systematic 
degradation. This degenerative response is driven partially by the cellular release of an excess of 
excitatory amino acids and consequent prolonged receptor activation that triggers an excessive 
Ca2+ influx and Ca2+-invoked activation of proteolytic and degradative enzymes, particularly 
cysteine proteases calpain and cathepsin (Yamashima, 2004). These enzymes breakdown 
cytoskeletal proteins and instigate reactive oxygen species release, leading to membrane damage 
and chemokine and cytokine production as well as other intracellular (ex. mitochondrial) 
dysfunctions (Bunge, 2008; Sauerbeck et al., 2011). 
Primary and secondary cell necrosis is regulated, at least in part, by phosphatidylinositol-
3-kinase (PI3K)/Akt signaling. Though activation of this pathway contributes to the prevention 
of cell death and to the enhancement of growth- and proliferation-associated cellular processes, 
Akt phosphorylation at and around the injury epicenter is abated after SCI, altering and rendering 
this pathway dysfunctional. This enervation contributes to the widespread necrosis at and around 
the injury site (Walker et al., 2012). 
 
Macrophages, Microglia, and Monocytes 
 
The non-neuronal cellular response to SCI recovery, however, is arguably a more 
effective target for improving recovery.  The immune system’s cells, such as neutrophils and 
macrophages/monocytes/microglia, invade the injury site as part of an acute inflammatory 
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response. These cells produce proteolytic and oxidative enzymes, such as matrix 
metalloproteinases, proinflammatory cytokines, and interleukins (ex. interleukin (IL)-1β, tumor 
necrosis factor (TNF)-α, IL-1, and IL-10), triggering a more comprehensive immune response 
(Nakajima et al., 2012; Wright et al., 2011; Zong et al., 2011). This response by the immune 
system includes processes that both promote and inhibit CNS regeneration and repair. Proteolytic 
and oxidative enzymes from immune cells can cause increased cavitation and cyst formation at 
the lesion site, exacerbating neurological dysfunction. However, macrophages have been found 
to phagocytose myelin debris in the injured spinal cord that could otherwise prevent axonal 
regeneration and also produce protective cytokines such as fibroblast growth factor (FGF), nerve 
growth factor (NGF), and neurotrophin-3 (NT-3), all of which promote neuronal regeneration 
(Nakajima et al., 2012; Shechter et al., 2011). The use of a cell type that can express these 
protective and growth-promoting factors while not producing the harmful factors that are 
expressed by the immune cells would be an ideal approach to improving recovery after SCI. 
 
Oligodendrocytes and Oligodendrocyte Precursor Cells 
Alongside the immune cell response is a momentous glial cell response. 
Oligodendrocytes (ODs) debilitated by the physical insult or by secondary lesions become less 
effective as myelinating agents, further impairing axonal action potential conduction. Damaged 
myelin sheaths, either due to the trauma itself or to OD death, break up into myelin debris 
chunks that are slowly collected by microglia and macrophages (Fawcett and Asher, 1999). 
Oligodendrocytes additionally express a set of compounds, including myelin-associated 
glycoprotein (MAG), Nogo-A, and oligodendrocyte-myelin glycoprotein (Omgp), that inhibit 
axonal regrowth. MAG, a potent inhibitor of neurite outgrowth, acts through the Nogo-66 
receptor (NgR) complex. Nogo-A’s inhibitory activity is mediated through its interaction with 
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NgR and other known and unknown Nogo-A receptors in the CNS, while Omgp’s inhibitory 
activity is dependent on the fidelity of the NgR complex alone, as cleavage of NgR renders 
axons insensitive to Omgp-induced growth inhibition (Gang et al., 2010; Wright et al., 2011; 
Zhilai et al., 2011;  etc.). 
After widespread OD necrosis and apoptosis, the replacement of myelin-producing cells 
becomes vital to functional recovery. Oligodendrocyte precursor cells (OPCs), which are present 
largely in white matter of the adult CNS, though they were first found in the optic nerve, 
proliferate and migrate to CNS injury site to remyelinate unmyelinated axons. While some OPCs 
mature into oligodendrocytes, the maturation of many OPCs is halted by either the inhibitory 
environment of the injury site or the lack of growth factors and molecular cues that promote full 
remyelination. Thus, remyelination by OPCs rarely reaches completion (Mekhail et al., 2012; 
Wu et al., 2011). Finding a more sustainable mode of remyelination is vital to improving 
functional recovery after SCI. 
 
Astrocytes 
A glial-cell directive, in which astrocytes become reactive and start expressing high 
levels of glial fibrillary acidic protein (GFAP), forms a scar around the fluid-filled cystic cavity 
that constitutes the lesion site. The newly formed scar encases the lesioned CNS site in a manner 
that effectively quarantines any exacerbating processes (ex. the destruction of healthy neural 
cells by reactive compounds and activated immune cells) while simultaneously preventing any 
extra-cystic elements (ex. regenerating axons) from interacting with the cyst. In fact, injured, 
regrowing axons terminate dystrophically at the outer margins of the lesion, indicating thwarted 
axonal growth (Fortun et al., 2009; Afshari et al., 2010; Deng et al., 2011). The deterrent nature 
of the glial scar is especially obstructive to axonal regeneration and regrowth. Though they help 
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to repair the blood-brain barrier and help to hault injury propagation, glial-scar astrocytes express 
a host of inhibitory compounds, of which the most significant are chondroitin-sulfated 
proteoglycans (CSPGs). CSPGs consist of a protein core to which glycosaminoglycan (GAG) 
side-chains are attached. These GAG side-chains have been suggested to be the basis of the 
inhibitory effect of CSPGs. It has also been shown that chondroitinase ABC, which cleaves these 
GAG side-chains, reduces CSPG-mediated inhibition of axonal regeneration in vivo and of 
neurite formation in vitro (Gang et al., 2010; Wright et al., 2011; etc.). The inhibition of the 
astrocytic obstruction of axonal regeneration is key for any SCI recovery improvement strategy. 
 
Schwann Cells 
Upon spinal cord injury, endogenous SCs invade the injured spinal cord milieu from the 
area of the spinal cord-nerve root junction in the proximal peripheral nervous system (PNS) to 
associate with regenerating axons (Blakemore, 1975; Blakemore, 1977; Duncan et al., 1988; 
Harrison, 1985). Each SC wraps itself around an axonal section, which constitutes a section of 
the myelin sheath around an axon, thus the myelin sheath around the axon of one neuron 
comprises numerous SCs. Each SC that has wrapped itself around one section of the axon 
localizes a certain distance from adjacent myelinating SCs, leaving spaces between myelinated 
sections of the axon constituting the Nodes of Ranvier. The newly created myelin sheath is 
surrounded by a unique basal lamina of mucopolysaccharides, which are secreted from the SCs 
(Fortun et al., 2009; Lavdas et al., 2008).  
In addition to re-myelination, SCs produce and release a volley of neurotrophic and 
growth factors, including NGF, brain-derived neurotrophic factor (BDGF), NT-3, FGF, glial-cell 
derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF). They additionally 
release various cell adhesion molecules (ex. integrins, N-cadherin, N-CAM, L1, and contactin) 
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and extracellular matrix proteins (ex. laminin, fibronectin, and collagens), additionally 
supporting regrowing axons.  
However, the endogenous SC response in SCI is limited and frequently ineffective in 
improving functional recovery. This is due, in part, to the limited migration of SCs that have 
invaded the CNS white and grey matter, even though they are typically highly migratory. Though 
restricted intra-CNS injury site migration of SCs may be attributed to reactive astrocytes, 
astrocytes have also been found to be stimulatory in SC migration when SCs and astrocytes are 
co-implanted, thus the reason for this impaired migration is still unknown (Afshari et al., 2010; 
Blakemore, 1975; Evercooren et al., 1997).  
SCs are arguably the most conducive SCI-responsive cell-type for functional recovery. 
SCs produce the protective and growth-promoting factors produced by macrophages and 
microglia, but do not producing the pro-inflammatory cytokines released by these cells. 
Additionally, when compared to oligodendrocytes, SCs can survive for long periods of time in 
the spinal cord lesion environment and are less susceptible to the necrosis/apoptosis promoting 
factors of the injury site. Also, SCs are less susceptible to autoimmune responses, such as in 
multiple sclerosis, than oligodendrocytes. In contrast to astrocytes, SCs do not produce 
significant amounts of compounds inhibitory to axonal regeneration. Also, astrocytes, unlike 
SCs, lack myelinating properties, making SCs the more desirable therapeutic candidate (Bunge, 
2002; Fawcett and Asher, 1999; Takami et al., 2002) 
Despite their many advantages, SCs remain an imperfect method by which to improve 
functional recovery after SCI. Possibly the most notable drawback is their limited ability to 
migrate away from the implantation or injection site (Afshari et al., 2010; Andrews & Stelzner, 
2007). This weakness is due, in part, to the tendency of SCs to spatially segregate from host 
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astrocytes, which inundate the CNS injury site. In fact growing astrocytes and SCs have been 
found to form stern boundaries upon contact in vitro and in vivo, though the full implications of 
this behavior have yet to be explored. Other factors that may contribute to the restricted Schwann 
cell migration include proteoglycans, heparin/FGF signaling, ephrin-eph signaling, and N-
cadherins (Afshari and Fawcett, 2012; Afshari et al., 2010). To address the problem of limited SC 
migration after implantation or injection, many groups have focused on combinatorial strategies 
in which SCs are coupled with growth-promoting, guidance-providing substrates and scaffolds to 
which they are allowed to attach and infiltrate prior to being implanted into animals. In this way, 
SCs can be initially provided throughout the injury site and, even after being implanted into the 
injury site, can use the guiding nature of the scaffold to migrate more effectively (Fouad et al., 
2005). Experiments presented in this paper reflect a pursuit of this concept, in an attempt to 
optimize the use of SCs, which present themselves as a promising strategy in SCI recovery, 
seeded on nanofiber scaffolds fashioned by electrospinning.  
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Chapter 2:  
SCI Repair Strategies 
 
Despite a rapid evolution of in vitro and in vivo research approaches to improve SCI 
repair, functional restoration and recovery successes have been limited (Joo et al., 2012). As 
mentioned, singular therapies have traditionally fallen under one of two classifications: (1) Those 
that block cues that inhibit regeneration and (2) those that provide or enhance growth-promoting 
cues. Though, many combinatorial and singular therapies employ both approaches. Specific 
goals for therapies addressing spinal cord injury include halting the spread of secondary tissue 
damage, curbing inflammation, reducing glial scar formation, neutralizing inhibitory factors, 
stimulating nerve fibers to regrow, nourishing surviving nerve cells, promoting physical fiber 
growth across the injury area, directionally guiding physical growth, and enabling connection 
establishment (Bunge, 2008). This section will overview strengths and limitations of some of the 
more popularly published therapy strategies, establish exogenous SC implants and the 
bioengineered scaffold implants as relatively promising therapies for SCI recovery separately, 
and then present an argument for their combination. 
 
Physical Rehabilitation 
Handicapped or non-existent standing and stepping patterns after a severe SCI have been 
shown to be resultant of a depressed state of spinal neuronal networks. However, neuronal 
circuits that experience repeated sensory and motor pathway activation can be reestablished and 
reinforced. This activity-dependent plasticity underlies the mechanism by which many 
rehabilitation studies achieve recovery. However, daily task-specific training improves the 
function of only the trained task (i.e. cats that had been intensively trained to stand exhibited an 
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improved capacity to stand, but had no apparent stepping improvements) (Musienko et al., 2011). 
Motor and sensorimotor recovery from exercise after SCI have been observed using behavioral 
and anatomical tests. Molecular quantification, such as measuring changes in levels of proteins 
such as BDNF, show results after just five days of exercise (Sandrow-Feinberg et al., 2009). 
Post-SCI exercise has also been found to stabilize lumbar motoneuron rhythmic firing patterns, 
increase levels of neurotrophic factors in the spinal cord, and reduce inflammation (Liu et al., 
2012). Physical rehabilitation has failed to produce prominent long-term effects, resulting in its 
frequent combination with other strategies.  
 
Glial Scar Digestion and Inhibitory Factor Neutralization  
Following secondary and tertiary tissue damage after SCI, an intrinsic inflammatory 
response ensues, contributing to cavitation and cyst formation at the lesion center and resulting 
in a glial scarring that is inhibitory to axonal regrowth and regeneration. Attempts to reduce or 
inhibit components of this glial scar have produced promising results. Cellular approaches 
include the acute injection of mesenchymal stem cells into an SCI site has been used to modify 
the inflammatory response to SCI to subsequently reduce scar tissue and cavity formation, thus 
creating a more permissive environment for axonal regeneration (Nakajima et al., 2012). This 
approach, though, addresses only the glial scar’s inhibition of regeneration; the remyelination of 
unmyelinated axons, the provision of neurotrophic/neurotropic factors to aid regeneration, and 
the establishment of an extracellular matrix (ECM) that is conducive to regeneration and 
guidance are all not addressed. 
Acellular strategies, have been shown to successfully suppress glial scar formation after 
CNS injury through mechanisms such as the attenuation of astrocytic activation and inhibitory 
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factor production, hence allowing axonal growth into the lesion cavity. The administration of 
hepatocyte growth factor (HGF), for example, has been found to reduce inhibitory CSPG 
expression and transforming growth factor (TGF)β levels as well as the activation of astrocytes 
in vitro and in vivo (Jeong et al., 2012). CSPGs, one of many ECM molecules that the glial scar 
comprises, are especially inhibitory to axonal growth and glial progenitor cell process outgrowth 
in vitro and in vivo, and thus chondroitinase ABC (chABC) has been used to effectively remove 
CSPG GAG chains, thus attenuating CSPG inhibitory activity (Bradbury et al., 2002; Siebert & 
Osterhout, 2011). However, the administration of factors that attenuate the inhibition of axonal 
regeneration addresses only one facet of SCI and tend to have a short therapeutic windows in 
vivo, since they may be degraded.  
 
Electrical Stimulation 
Altered signal transmission in surviving and regenerating axons after SCI, which 
underlies various components of SCI pathology, can be attributed to conduction deficits in 
response to increased action potential thresholds (Hunanyan et al., 2012). Thus, electrical 
stimulation can be used to induce action potentials by overcoming high thresholds. Tonic 
epidural electrical stimulation has been shown to restore hindlimb movements in otherwise 
paralyzed rats, and it has thus been coupled with physical rehabilitation strategies to improve 
recovery in various animal models (Courtine et al., 2011). Additionally, electric fields have been 
successfully implicated in improving cell (astrocyte) migration and enhancing cell 
(oligodendrocyte) viability in CNS injury models (Gary et al., 2012; Li et al., 2010). Though 
focal electrical stimulation may be able to change many aspects of cell behavior, the more 
clinically-relevant stimulation of various cells or tissues may alter important physiological 
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micro- and macroscopic electrostatic forces, thus possibly altering important homeostatic 
balances. 
 
Neurotrophic/Neurotropic Factor Delivery 
The topical administration of neurotrophins/neurotropins (NTPHs/NTPs), including NGF, 
BDNF, GDNF, and insulin-like growth factor (IGF-1) have been shown to improve functional 
recovery after SCI. BDNF or IGF-1 administered onto the SCI site induces neuroprotection, 
while the topical administration of BDNF with IGF-1 and GDNF improved motor function just 
90 min after SCI (Sharma & Sharma, 2012). Topical administration, however, does not afford the 
spatial and temporal control of NTPH/NTP release offered by cells or degradable polymer 
carriers. Thus, a host of different vehicles, including cells and polymer encasings (ex. beads), 
have been used to deliver neurotrophic/neurotropic and growth factors in in vivo and in vitro SCI 
models. When administered locally, these extrinsic signaling cues have been shown to 
significantly improve axonal survival and regrowth/regeneration, and subsequently functional 
recovery (Krick et al., 2011; Sharma & Sharma, 2012). The therapeutic window duration of this 
method is a direct function of properties of the biomaterial used to fashion the encasing, thus 
limiting NTPH/NTP release to parameters set by these material properties. Whereas polymer 
beads may have limited molecular release durations, cells that are implanted into injury 
environments in vivo may be able to survive, replicate, and thrive. Thus cells that innately or that 
have been engineered to produce desired NTPHs/NTPs are attractive administration alternatives. 
The delivery of growth and neurotrophic/neurotropic factors via cells has produced promising 
results.  Many cellular strategies to SCI repair and regeneration have focused on using 
transplanted SCs as a source of neurotrophic/neurotropic factors (Bunge, 2008). In fact, human 
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bone marrow-derived mesenchymal stem cells (hMSCs) induced to adopt SC characteristics 
have been found to express SC-specific proteins, to adopt an SC-like morphology, and to secrete 
higher concentrations of several growth factors, such as vascular endothelial growth factor 
(VEGF) and HGF, usually secreted by normal hMSCs. Thus, like SCs, these altered hMSCs 
produce a host of neurotrophic and neurotropic factors (Park et al., 2010). 
 
Re-myelination 
Two of the most popularly researched molecular approaches to post-SCI myelin repair 
are (1) preserving existing oligodendrocytes and (2) increasing the presence of myelinating 
agents, such as oligodendrocyte precursor cells, olfactory ensheathing cells, and Schwann cells 
(Mekhail et al., 2012; Tharion et al., 2011).  
The preservation of existing myelinating cells after SCI, though relatively unimodal, has 
opened promising avenues of pursuit. The rescue of apoptotic oligodendrocytes, reduction in 
myelin loss, and subsequent improvement in functional recovery are all seen after the 
administration of gastric hormone ghrelin, which is known to stimulate growth hormone release 
from the hypothalamus and pituitary gland (Lee et al., 2010). Successful attempts to preserve 
existing myelinating cells after SCI also include the use of topiramate, a 2-amino-3-(5-methyl-3-
oxo-1,2- oxazol-4-yl)propanoic acid (AMPA)-specific glutamate receptor agonist that is FDA-
approved to treat CNS disorders, and leukemia inhibitory factor, which acts through JAK/STAT 
and Akt signaling (Azari et al., 2006; Butzkueven et al., 2006; Gensel et al., 2012). 
To supplement the preservation of surviving oligodendrocytes, a faction of research 
studying remyelination after nerve injury research has focused on adding myelinating agents, 
such as oligodendrocytes (ODs), oligodendrocyte precursor cells (OPCs), olfactory ensheathing 
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cells (OECs), and Schwann cells SCs). Increasing oligodendrocyte number at and around the 
injury site has been shown to improve action potential conduction in initially amyelinated axons 
(Almad et al., 2011; Utzschneider et al., 1994). Strong evidence has been shown to support that 
the transplantation of OPCs (Keirstead et al., 2005; Wu et al., 2011), OECs (Novikova et al., 
2011; Tharion et al., 2011) and SCs (Bunge, 2008; Chen et al., 2002; Deng et al., 2011) improve 
remyelination in the injured cord and enhance functional recovery after SCI. The use of non-OD 
cell types resulted from the hostility to ODs displayed by the post-SCI environment. Of the 
myelinating cells, SCs seem to be the best choice for addressing the multifaceted impact of SCI. 
Compared to SCs, OECs have been shown to be less viable and to provide less myelination post-
implantation.  Likewise, OPCs, though viable in the hostile post-SCI environment and an active 
remyelinating agent of denuded axons, produce myelin that is thinner, has shorter internode 
segments, and irregular ratios of axon radius to axon plus surrounding myelin radius. Though 
myelination by SCs after SCI has resulted in imperfect action potential conduction, many groups 
cite ease of culturing and harvesting large numbers of SCs, as well as potential ease of clinical 
translation since SCs could be taken from patients’ peripheral nerves, as reasons for pursuing 
SCs over OECs and OPCs (Bunge, 2008; Oudega, 2007; Pearse et al., 2007). 
 
Axonal Guidance Support 
Though biochemical approaches, such as supplemental myelination and trophic/tropic 
factors, to improve SCI recovery have produced partial success stories, the misdirection of 
regenerating axons accounts at least partially for relatively poor functional performance results 
from many therapies.  Thus, physical guidance and microenvironment support for regrowing 
axons are essential for significantly advancing improvement (Gordon et al., 2003; Krick et al., 
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2011; Liu et al., 2011). The construction of scaffolds and conduits from synthetic and natural 
biomaterials to provide axonal guidance support has been a principal approach to improve SCI 
recovery for decades (Hadlock et al., 2000).  These scaffolds/conduits can serve to bridge gap 
sites in lesioned neural tissue. The importance of this bridging is highlighted by reports such as 
the presence of axons within trabeculae crossing the lesion, implying that axons, when provided 
with an appropriate substrate, such as a bridge, will grow into and across an injury site regardless 
of glial scar presence (Fortun et al., 2009). However, without the perfect parameters to support 
regenerative guidance, a bridge may not have any effect. 
Bridge design parameters include scaffold composition (i.e. mechanical properties), size 
and shape, biocompatibility, biodegradability, porosity/mesh size, capacity to appropriately house 
cells or molecules, and capacity to adapt to various needs. Scaffold designs can arguably be 
divided into two major categories: 1) solid, preformed scaffolds and (2) injectable liquid or gel 
scaffolds (Bueno et al, 2007; Du et al., 2011; Macaya and Spector, 2012). Approaches that have 
employed preformed scaffold implantation have utilized materials such as collagen, poly-ε-
caprolactone (PCL), polylactic-co-glycolic acid (PLGA), poly-L-lactic acid (PLA), 
methylcellulose, fibrin, hyaluronic acid (HA), oligo polyethylene glycol fumarate (OPF). 
Scaffold-fashioning methods have included fiber cross-linking, gelation, and electrospinning 
(Cholas et al., 2012; Ding et al., 2011; Joo et al., 2012; Liu, et al. 2012; McCreedy & Sakiyama-
Elbert, 2012; Saadai et al., 2011; Wei et al., 2010). Compared to solid implantable scaffold 
materials, injectable materials, such as liquids that become gels or solids, have the advantage of 
being able to fill physical defects and to form scaffolds with integrative implant-tissue interfaces. 
Injectable scaffold materials include collagen, agarose, HA, tetronic-oligolactide, chitosan, and 
poly(N-isoproylacrylamide)-polyethylene glycol. Utilization methods include liquids that 
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become gels or solids, gels that become solids, liquids that remain as liquids, and gels that 
remain as gels. Guidance support strategies are frequently used in combination with other 
strategies, since other facets of SCI lesions are usually disregarded in experiments with only 
scaffold therapies (Macaya and Spector, 2012). 
 
Cellular Implants 
As established, the most successful structural and functional restoration after SCI requires 
at least neuro-rehabilitation and regeneration. Cellular implants can be used to address both of 
these restoration requirements. Commonly employed cell types can operably be divided into two 
major categories: (1) cells that can differentiate into or that already display neural phenotypes 
typically found in the adult spinal cord and (2) cells that do not differentiate to become or that 
are not phenotypically imitative of cells typically found in the adult spinal cord (Leung et al., 
2012; Novikova et al., 2011; Sandner et al., 2012). 
Therapies using cells that can differentiate to or that already display neural phenotypes 
utilize stem cells (ex. embryonic, fetal, adult mesenchymal, neural, or endothelial) and precursor 
cells (ex. oligodendrocyte precursor cells), though oligodendrocytes and astrocytes have also 
been implanted to promote functional recovery (Davies et al., 2011; Erceg et al., 2010). Multi- or 
pluripotent stem cell strategies are implemented with the hope that the appropriately 
differentiated neural cells will replace lost cells and will serve to support axonal regrowth and 
regeneration. Mesenchymal stem cells have been found to enhance remyelination and improve 
functional recovery of motor skills in rats and dogs (Karaosz et al., 2012; Park et al., 2012; 
Sandner et al., 2012). Umbilical cord blood stem cells have additionally been shown to 
upregulate matrix metalloproteinase-2 levels, reducing glial scar formation and further allowing 
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for axonal regeneration (Veeravalli et al., 2009). Though stem cells have the ability to 
differentiate into neurons or glial cells and thus exhibit different properties, such as myelination 
or neurotrophin/neurotropin release, the regulation of stem cell differentiation can be complex 
and difficult, adding more possible variables to a successful stem cell therapy formula. The use 
of a mature cell type, that provides myelination and trophic/tropic support to regrowing axons, 
may have fewer variables, since differentiation would not be a requisite (Karaosz et al., 2012; 
Sandner et al., 2012).  
The other group of cell types commonly used to improve SCI recovery, namely those that 
are not and cannot differentiate into cells that display adult spinal cord cell phenotypes, includes 
Schwann cells and olfactory ensheathing cells (Leung et al., 2012; Novikova et al., 2011; 
Sandner et al., 2012). Both have induced improved functional recovery after SCI in various 
animal models through either the myelination of unmyelinated axons or the provision of 
important neurotrophic/neurotropic factors  (Deng et al., 2011; Wang et al., 2011; Ziegler et al., 
2011). 
 
Other Strategies 
Less commonly published strategies include the supplementation of VEGF (Lutton et al., 
2012), polyunsaturated fatty acids (Ward et al., 2010), ethyl pyruvate (Yuan et al., 2011), and 
naturally-occurring anti-inflammatory curcumin (Lin et al., 2011; Ormond et al., 2012). Also, the 
cellular damage and death induced by oxygen free radicals after SCI has recently been a major 
target for improving functional recovery after SCI. Antioxidants and free radical scavengers, 
such as edaravone and resveratrol, have been shown to reduce the effect of free radicals such as 
nitric oxide, malondialdehyde, superoxide dismutase, and glutathione peroxidase after SCI 
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(Ozgiray et al., 2012). These and many other approaches, unfortunately, are uni-dimensional in 
nature, and therefore are suboptimal or require combination. As overviewed, the use of SCs 
alternatively affords a multi-dimensional approach to SCI recovery, making them strong 
candidates for inclusion in therapies. Also mentioned earlier, SCs exhibit limited migration and 
do not provide a way to physically guide regrowing and regenerating axons. Scaffold 
implantation can supplement this insufficiency while providing a substrate on which to 
administer cellular or acellular entities, such as SCs. 
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Chapter 3: 
Bioengineering: Electrospinning Scaffolds to Facilitate Axonal Regeneration after SCI 
To properly host viable SCs or facilitate any sort of recovery after SCI, scaffolds must 
meet several requirements. Bioengineering affords the convenience of being able to tailor the 
scaffold design to the specific demands of the model. Design considerations should first address 
the ability of a scaffold to independently promote axonal regeneration and functional recovery 
from SCI, then a scaffold’s capability to carry and support therapeutic cells, 
neurotrophic/neurotropic factors, and other neuroprotective or neuroregenerative compounds, 
and finally the ability of a combined therapeutic model of scaffold and compound to improve 
recovery after SCI. 
Mimicking the three-dimensional, complex architecture of the nano-, micro-, and macro-
environment that constitutes the ECM of the injury site has been a primary goal of recent 
scaffold fabrication (Gordon et al., 2003; Krick et al., 2011; Liu et al., 2011; Srouji et al., 2008). 
This pursuit of the ideal scaffold in various SCI models has informed the list of important factors 
that contribute to scaffold success. These factors include scaffold composition (i.e. material), size 
and shape, biocompatibility, biodegradability, the capacity to appropriately house exogenous 
cells or molecules, the capacity to support the survival and directional growth of endogenous 
neurons and glial cells, and the capacity to adapt to various needs (Bueno et al, 2007; Dewitt et 
al, 2009; Du et al., 2011; Kim et al., 2007). 
Though initially patented in 1934, electrospinning has only recently enjoyed growing 
popularity. The basic format consists of a blunted needle fitted to a syringe, filled with the 
dissolved scaffold material, which is mounted onto a machine that controls solution expulsion 
from the needle. The solution is passed through a graded electrostatic field, generated by a high 
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voltage (1-50 kV) source, and onto a grounded collector (for fiber deposition). Basic 
configurable parameters include needle tip-to-target distance, applied voltage, and volume flow 
rate (of the substance exiting the needle). The grounded collector can either be one solid, 
uniformly charged metal conductor, in which case the process is referred to as conventional 
electrospinning, or multiple, equally charged metal conductors separated by air, in which case the 
process is termed air-gap electrospinning. Both methods have produced scaffolds with neuronal 
ECM-like properties from a variety of materials (Jha et al., 2011; Srouji et al., 2008).  
Several groups have suggested the success of electrospun scaffolds to promoting axonal 
regeneration and functional recovery after nerve injury. Electrospun PLGA-silk fibroin-collagen 
scaffolds have been characterized as displaying appropriate hydrophilicity, fiber diameter, and 
porosity to host therapeutic cells and promote nerve regeneration (Wang et al., 2011). Silk-
fibroin electrospun scaffolds have similarly been shown to appropriately host and support cells 
therapeutic for SCI, such as olfactory ensheathing cells (Shen et al., 2010). Additionally, 
electrospun resorbable material polydioxanone has been suggested to support neurite outgrowth 
to different degrees depending on electrospinning-dependent parameters (Chow et al., 2007). 
Electrospun poly-L-lactic acid fibers have been shown to directionally support axonal regrowth 
(Schaub & Gilbert, 2011). 
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Chapter 4: 
Schwann Cell Infiltration and Migration into Electrospun Scaffolds 
Packed with fiber layers on the micrometer or nanometer scale, electrospun scaffold 
morphology is highly tunable. Various parameters, such as material, fiber diameter, pore size, 
and solvent used all affect cellular response to the biomaterial. A major variable is the number of 
dimensions in which the scaffold is fabricated. Though electrospinning has traditionally 
produced two-dimensional scaffolds, three dimensions allows for salient, interconnecting pores 
between nanofibers, thus closely mimicking the native ECM and increasing the likelihood of cell 
and functional tissue survival (Blakeney et al., 2011). 
Cell infiltration and migration into three-dimensional scaffolds have become primary 
goals for SCI recovery approaches employing seeded or interlaced electrospun scaffolds. An 
unfortunate, yet characteristic, paradox of the electrospinning process is that it does not afford 
both optimal cell attachment and cellular infiltration simultaneously, since if porosity is 
decreased and fiber packing density increased in order to strengthen planar structure and improve 
cell seeding and attachment, cellular infiltration can be compromised. An easily-altered 
parameter, scaffold porosity has recently become a popularly researched and published focus. 
Additionally, its direct effect on cell seeding and infiltration, make it an attractive focus of study 
(Blakeney et al., 2011; Vaquette, et al., 2011). Recent research on cellular-based combinatorial 
strategies utilizing electrospun scaffolds to facilitate SCI repair has shown promising advances in 
the seeding, migration, and infiltration of various cell types, especially SCs (Griffin et al., 2011; 
Jeffries & Wang, 2012; Wang et al., 2010; Wang et al., 2011). 
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Current Study 
The current study evaluates SC migration into three-dimensional (3D) electrospun 
scaffolds and hypothesizes that SC migration across two-dimensional (2D) scaffolds, also 
generated through electrospinning, will be more improved by MatrigelTM than by laminin. We 
then aim to confirm results from other studies that MatrigelTM and SCs independently improve 
functional recovery after SCI. Furthermore, we hypothesize that, after a complete transection at 
the eighth thoracic vertebra (T8) in rats, the combined treatment of MatrigelTM, an electrospun 
guidance and support scaffold, and SCs (seeded and grown on the electrospun scaffold) will 
more effectively improve recovery, as measured by the restoration of urine volume retained, 
hindlimb motor control, and body weight, than the independent effect of the electrospun scaffold 
and the combined effect of MatrigelTM and electrospun scaffold. We hope, through our in vitro 
and in vivo studies, to be able to characterize the combination of electrospun polydioxanone, 
SCs, and MatrigelTM as a strong potential tactic for improving functional recovery after SCI in 
rats. 
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METHODS 
Schwann Cell Culturing 
Primary rat SCs were obtained from SciencellTM Research Laboratories (Catalog Number 
(#): R1700). Upon receipt, cells were grown in Schwann cell medium (SciencellTM Research 
Laboratories, Catalog #: 1701) to 90% confluency and then passaged up to three times. Cell 
medium was replaced the day following a passage and every other day afterward until the next 
passage. Schwann cell purity, as determined by counting immunostained cells, was found to be 
95.6% at the first passage, 94.1% at the second passage, and 94.8% at the third passage. 
 
Scaffold Engineering/Construction – Electrospinning 
Biomaterial Preparation – Polydioxanone Suture Dissolution 
Polydioxanone suture (PDS) (EthiconTM; Catalog Name/Number: PDS* II/Z762D) was 
cut into three-inch-long pieces and gently shaken and dissolved in 1,1,1,3,3,3-Hexafluoro-2-
propanol (HFP) (Oakwood Products, Catalog #: 003409), also referred to as 
hexafluoroisopropanol (HFIP), at a concentration of 100mg/ml (100mg of PDS in 1mL of HFP) 
in a 10mL plastic syringe for 20 hours. A blunted-tip, hypodermic needle (18 gauge, 1.5 inches 
long, Becton Dickinson & Co. PrecisionGlide®) was then fixed to this syringe, which was then 
fastened into a syringe pump (KD Scientific, Catalog Number: KDS100). The syringe pump 
flow rate (rate of solution extrusion from needle) for air-gap electrospinning was 9 mL/hour 
while the flow rate for traditional, or mandrel, electrospinning was 8 mL/hour.  
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3D Scaffold Material Collection - Air-Gap Electrospinning Setup 
The air-gap electrospinning collecting apparatus, onto which charged fibers land after 
being extruded from the needle, consisted of two separated, identical, static, grounded metal 
spheres (radius = 1.0 cm) atop plastic poles that raised the stainless steel spheres to the same 
height as the syringe (for optimized fiber collection). The two spheres were placed 10 cm apart 
from each other, with two cylindrical rods (length = 2.5 cm, radius = 1.0 mm) as landing targets 
for the material coming from the needle, extended from each sphere directly towards each other, 
oriented perpendicular to the orientation of the needle. Thus, a 3.0 cm gap of air for fiber 
distribution and collection was created between the two rods; it is in this gap that the scaffold 
was constructed, bridging the ends of the two rods. These rods supported and facilitated the fiber 
collection and eventual scaffold fabrication. The result was a long, cylindrical, non-woven, 
fabric-like sheet of polydioxanone fibers of nanometer-scale diameters. 
 
2D Scaffold Material Collection – Conventional (Mandrel) Electrospinning Setup 
The collecting apparatus for the traditional electrospinning consisted of one rectangular, 
grounded spinning (1000 revolutions/min) stainless steel block (80Lx20Wx2H mm) raised to an 
optimal height to serve as a landing surface for incoming charged fibers and oriented 
perpendicularly in relation to the syringe and needle. An even, non-woven sheet, resembling 
fabric, of polydioxanone fiber with nanometer-scale diameters, was dispensed over the block’s 
complete surface. 
 
 
 
26 
 
Scaffold Construction - Electrospinning 
For both electrospinning methods, the positive output lead of a high voltage supply 
(Spellman High Voltage Electronics Corporation; Catalog #: CZE1000R), set to 15 kV for the 
air-gap method and 20 kV for the conventional (mandrel) method, was attached via alligator clip 
to the needle on the syringe, while the negative output lead of another high voltage supply, also 
set to 15 kV, was attached to the collecting apparatus. Spinning duration was 15 minutes, or until 
the desired radius was achieved, for the air-gap electrospinning method and 45 minutes for the 
traditional electrospinning method. Two separate, near-identical air-gap electrospun products (3.0 
mm long) were fabricated and processed immediately after one another, while only one 
traditional electrospun product was obtained and processed for experimental use (Figure 1.1). 
 
Air-Gap Electrospun (3D) Scaffold Preparation 
Slicing 
The 3.0 cm-long cylindrical electrospun polydioxanone product were cut from the 3.0 cm 
gap between the rods in which the fibers were collected. The scaffold was placed into a clear 
acrylic David Kopf® Instruments brain blocker (Catalog #: PA001) and 0.75 cm was cut from 
each end and discarded, since the physical properties of these ends, that were closest to the 
collecting rods of the air-gap electrospinning apparatus, were markedly different from the center 
1.5 cm of the cylindrical scaffold product. This remaining 1.5 cm scaffold centerpiece was 
carefully, in a steady sawing motion, cut into 1 mm-thick cylindrical pieces that retained the 
same diameter of the original uncut product. Since two 3.0 cm-long products were fabricated, 
two 1.5cm centerpieces were obtained. Thus, 30-1 mm-thick scaffolds were sliced, of which 18 
were used for in vivo rat SCI model experiments, 4 were used for in vitro cell-on-scaffold 
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characterization experiments, 3 were used for cell migration-through-scaffold experiments, 2 
were used for scaffold characterization experiments, and 3 were discarded due to improper 
slicing or loss of physical integrity during or after slicing. The average diameter ± standard 
deviation (SD) of the 27 sliced 1mm-thick scaffolds that were experimentally implicated was 
3.72 ± 0.07394 mm. 
 
MatrigelTM Coating 
All MatrigelTM-coating was done in a sterilized cell culture hood (nuAire, Inc.). Room 
temperature-thawed BD MatrigelTM (BD BioSciences, Catalog #: 356237 ) was injected into one 
well of a sterile 96-well plate well (about 75% to the rim). 20 of the 27 total scaffolds were 
sterilized in a 35mm petri dish 70% EtOH for 30 minutes, allowed to dry, soaked in SC medium 
for 10 minutes, then dipped in the MatrigelTM -filled well and swirled around by the 
experimenter via forceps for 30 seconds. After, 20 of the 27 total scaffolds were coated in 
MatrigelTM, scaffolds were then each placed in separate wells of a 96-well plate to await the 
application of cells or control (cell-free SC medium). 
 
Cell Seeding 
All cell seeding was done in a sterilized cell culture hood. Five, of the remaining seven, 
MatrigelTM-free scaffolds  were sterilized for 30 minutes in 70% EtOH and then added to 
separate wells of the same 96-well plate as the aforementioned 20 MatrigelTM-coated scaffolds, 
in a manner that they could be distinguished from the other scaffolds. Cells were prepared for 
seeding at the first or second passage. SCs were isolated after centrifugation in their first or 
second passage, resuspended in 100 µL of cell medium, and submitted to a count via 
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haemocytometer; trypan blue was used to exclude organic debris and dead cells in the count. 
After a cell density (cells/mL) was obtained, the appropriate amount of cell medium was 
calculated and then added to the suspension to dilute the solution so that every 6.5 µL of cell-
containing medium contained 74,300 cells. This total number of cells to be seeded on each 
scaffold was determined by calculating how many SCs could spatially fit, without overlapping, 
on one circular surface of the 1 mm-thick cylindrical scaffold. For this calculation the average 
area of one scaffold face, from an observed average scaffold diameter of 3.72 mm, was divided 
by the average area of an SC, which was calculated from an observed average SC diameter of 12 
µm. To optimize cell seeding efficiency, or the percent of applied cells (74,300) that were, 
indeed, seeded onto the scaffold via attachment, it was decided that cells would be seeded onto 
the scaffolds by pipetting a droplet of cell-containing medium that, when settled around the 
scaffold, was as small as possible while still fully enveloping the scaffold; this specification was 
met with a 6.5 µL aliquot. Thus, 6.5 µL of cell-containing medium, at a concentration of 74,300 
cells in every 6.5 µL (11,431 cells/µL), was slowly and carefully pipetted onto the top surface of 
19 MatrigelTM -coated scaffolds. 6.5 µL of cell-free medium was pipetted onto the surface of 4 
MatrigelTM-coated and the 2 MatrigelTM-free scaffolds, all of which were in separate wells of a 
96-well plate which was promptly covered and placed in a sterilized, humidified CO2 incubator 
(Sanyo) at 37oC and 5.0% carbon dioxide. After 3 hours (to allow for initial cell attachment), the 
plate was slowly removed from the incubator, minimizing shaking and liquid movement. Each 
scaffold was then cautiously picked up via forceps, turned upside-down, and placed back in the 
same well, so that the side that was previously seeded with cells was facing the bottom of the 
well, and the un-seeded side was facing upwards. 6.5 µL of cell-containing medium was then 
applied to upward-facing side of 6 scaffolds that had previously received cells, while the 
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remaining 19 scaffolds (10 with Matrigel and cells on one side, 4 with only MatrigelTM, and 2 
with neither MatrigelTM nor cells) received 6.5 µL of cell-free SC medium. Scaffolds were again 
incubated for 3 hours and then each scaffold-containing well was filled 50% will cell-free SC 
medium and left to incubate for 5 days. Cell medium was changed daily.  
 
Cryostat Slicing for SC Dispersion Characterization 
To profile the extent of migration/infiltration into the 3D scaffolds, three scaffolds were 
sliced into 25 µm-thick sections, via a cryostat (Thermo Scientific, property of the Microscopy 
Core Facility, Virginia Commonwealth University). Every other sliced section was discarded so 
that sections were collected every 50 µm. 
 
Seeding SCs onto Two-Dimensional Traditional Electrospun Scaffolds 
Scaffolds were removed from around the rectangular mandrel of the traditional 
electrospinning apparatus as one sheet and cut, using a single-edge razor blade, into flat, square 
scaffolds (5 mm x 5 mm). They were sterilized in 70% EtOH for 30 minutes, allowed to dry, 
soaked in SC medium for 10 minutes, immersed in a 35mm x 10mm petri dish of either 1X tris-
buffered saline (TBS) (50mM Tris-Cl + 150mM NaCl), as the control, laminin, or MatrigelTM, 
and left in a sterile environment overnight (16 hours). Scaffolds were placed into separate wells 
(of a 48-well culture plate well). SCs were isolated after centrifugation in their third passage, 
resuspended in 50 µL of cell medium, and submitted to a count via haemocytometer; trypan blue 
was used to exclude organic debris and dead cells in the count. After a cell density (cells/mL) 
was obtained, the appropriate amount of cell medium was calculated and then added to the 
suspension to dilute the solution so that every 1.0 µL of cell-containing medium contained 
30 
 
20,000 cells. 20,000 cells were pipetted onto the visually-determined center of each 5 x 5 mm 
square, each in their own well. 100 µL of cell-free cell medium was pipetted around the base of 
each scaffold-containing well to keep scaffolds hydrated, after which the whole 48-well plate 
was incubated at 37oC and 5.0% carbon dioxide. 
 
The Surgical Implantation of Scaffolds into Animals 
Scaffold Preparation 
Prepared scaffolds were removed from incubation after 5 days and split into seven 
experimental groups, including 5 groups implicated in in vivo experiments via surgical 
implantation (N=4 for all 5 groups, unless otherwise noted):  
(1) scaffold + MatrigelTM + SCs on both sides;  
(2) scaffold + MatrigelTM + SCs on one side (implanted with cellularized side facing rostrally);  
(3) scaffold + MatrigelTM + SCs on one side (implanted with cellularized side facing caudally);  
(4) scaffold + MatrigelTM + control treatment (SC medium);  
(5) scaffold + control treatment (SC medium) (N=2); 
 
For simplification, for the remainder of the paper, all 3D scaffolds that were implanted into 
animals (in vivo) will be referred to as “bridges”. The above groups will thus forth be referred to 
as the following: 
(1) SC bridges (both sides);  
(2) rostrally-facing SC bridges; 
(3) caudally-facing SC bridges; 
(4) MatrigelTM-only bridges;  
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(5) control bridges; 
 
All bridges were washed 3 times for 3 minutes each in Hank’s Balanced Salt Solution (HBSS) 
prior to implantation. Accordingly, 18 rats were split into 5 groups: 4 groups (N=4) + 1 group 
(N=2).  
 
Surgical Procedure - Complete Spinal Cord Transection 
Adult female, Long Evans Hooded rats, of mean (SD) weight = 308.4 (16.5)g, acquired 
from Harlan Inc, were used partially because of the reported decreased incidence of urinary tract 
infections in female, compared to male, rats after SCI, and because of the easily manageable 
behavioral traits of Long Evans Hooded rats, compared to other common experimental strains, to 
allow for easy daily bladder expression and handling. Bladder expression was necessary because 
of abnormally high urine retention and lack of auto-expression post-SCI. All surgical procedures 
were performed in accordance with the guidelines set forth by the Institutional Animal Care and 
Use Committee. Animals were anesthetized in a clear, sealed container with 5% isoflurane, 
shaved (from lower-back to shoulders), and fitted into a stereotaxic surgical apparatus (Stoelting) 
without the manipulator arms. After 2-3 minutes of stable isoflurane administration and testing 
for complete anesthesia via toe and tail pinches, isoflurane dosage was reduced to 2-3%, 
betadyne was applied to the shaved skin area, and a percutaneous dorsal, midline incision of 
about 4 cm was made above the mid-thoracic spine with a scalpel (No. 10 blade), exposing a 
thick layer of fat which was partially removed to expose the layer of muscle covering the spine. 
Incisions were made bilaterally of the spinal column and the protective muscle was forced aside 
and further separated by stainless steel tissue spreaders (Codman) to further isolate the spinal 
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column and increase the working area. Stainless steel tissue forceps (Codman) were used to clear 
inter-process tissue and lempert bone rongeurs were used to perform a conventional 
laminectomy, in which the lamina, along with the rest of the spinal column’s posterior backbone, 
was removed at the eighth thoracic vertebra (T8), fully exposing the dura mater (dura)-encased 
spinal cord (Figure 1.2a). A complete spinal cord transection was performed using micro-
scissors, resulting in two nerve stumps (one rostral and one caudal to the transection site) 
separated by a less than 1mm gap. An HBSS-washed 1 mm-thick cylindrical scaffold, from one 
of the five groups identified in “Scaffold Preparation” above, was implanted between the two 
stumps, serving as a bridge (Figure 1.2b). Following implantation, separated muscle layers were 
pulled back and sewn together using silk suture (Ethicon Perma-Hand Silk, Catalog #: 682G). 
Surgical staples were used to close the skin incision. After removal from the surgical apparatus, 
the animals were placed on an electrical heating pad to counteract any body temperature drops 
and visually monitored until consciousness was regained. Rats were administered 2 mL of 
gentamicin sulfate (GentaFuse [Butler], diluted to 1 mg/mL in 9g/L (normal) saline) and 0.25 mL 
of buprenorphine (0.5 mg/kg); 5 mLs of liquid acetaminophen (150 mg/kg) was diluted into the 
each animal’s drinking water container. Rats were visually monitored for consciousness and 
forelimb activity every 10 minutes for up to one hour, or until stable. 
 
Post-Operative Animal Care 
Rats were housed in separate cages and administered 2 mL of gentamicin sulfate (1 
mg/mL) every 12 hours for 7 days and 0.25 mL of buprenorphine (0.5 mg/kg) every 12 hours for 
48 hours; liquid acetaminophen remained diluted in rats’ drinking water containers for 3 days, 
and then replaced with plain tap water. Rats were individually monitored (for general 
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appearance/health and urine color) and their bladders depressed by experimenter hand every 12 
hours, while body weight and results from a four sub-scale score of moribundity were taken 
every 24 hours (moribundity was measured using a 3-point scale, from 0 (normal) to 2 (severe), 
of appearance, weight, eyes, and activity . Expressed urine volume and pH was measured every 
48 hours. pH measurements were stopped after 8 days of a consistent pH measurement of 7, 
though all other measures were taken for the duration of the animal’s life. Drop-wise 
clindamycin (25 mg/ml) was administered to effectively halt self-mutilation behavior. 
 
Locomotor Activity Testing 
Hindlimb locomotor activity and motor control was assessed via a double-blind 
employment of the 22-point Basso-Beattie-Bresnahan (BBB) Locomotor Rating Scale (Figure 
1.3), with 21 constituting complete mobility and 0 constituting complete hindlimb paralysis. The 
BBB scale considers parameters such as joint mobility, weight support, limb coordination, and 
gait stability.  Rats were placed in a circular open field (radius ~ 38 cm; plastic, light-brown 
tabletop with a bounded perimeter) and allowed to freely perambulate the tabletop surface for a 
three-minute time period (Figure 1.4).  Animals were scored pre-surgery and immediately post-
surgery to establish baseline scores. Then, animals were scored every 4 days. Raw BBB scores 
represent an average of two independent scorers (the averaged score range never surpassed ±1 
from this raw score; ex. a raw score of 8 might have been averaged from independent observer 
scores of 7 and 9, but not 6 and 10).  
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Immunostaining, Imaging, and Slicing – In Vitro Analysis 
To quantify cell-seeding efficiency, all non-implanted scaffolds with SCs were fixed in 
4% paraformaldehyde at the appropriate time points (5 days after seeding for 3D air-gap 
electrospun scaffolds; 0, 3, 5, and 7 days after seeding for 2D traditionally electrospun scaffolds). 
Cells were then co-stained for cell nuclei and the intracellular (IC) protein families S100A and 
S100B, which were used to identify SCs (Mata, Alessi, and Fink, 1990). For SC identification 
via the S100 protein, cells were permeabilized using 0.25% Triton X-100 and 1% bovine serum 
albumin (BSA) was used as a blocking agent. The whole cell-seeded scaffold was incubated, 
overnight at 4oC, in diluted primary antibody S100 (polyclonal anti-rabbit) (Dako, Catalog #: 
Z0311) at a dilution factor of 1:800 (in phosphate-buffered saline (PBS)-diluted permeabilizing 
and blocking agents). The scaffold was then incubated, for 1 hour in the dark at room 
temperature, in diluted secondary antibody AlexaFluor 568 (goat, anti-rabbit IgG) (Invitrogen, 
Catalog #: A-11036) at a dilution factor of 1:200 (in PBS-diluted permeabilizing and blocking 
agents). Scaffolds were then stained for nuclei using a 1:1000 dilution factor of bisbenzimide for 
2 minutes (courtesy of Dr. Jeff L. Dupree, Ph.D., Virginia Commonwealth University). Samples 
were then imaged using either a laser scanning confocal microscope (Leica TCS-SP2 AOBS 
CLSM, property of the Microscopy Core Facility, Virginia Commonwealth University) or a 
scanning electron microscope (Zeiss EVO 50 XVP SEM, property of the Microscopy Core 
Facility, Virginia Commonwealth University). For 3D cell migration studies, scaffolds were 
immunostained, sliced, and then imaged using laser scanning confocal microscopy.  
 
 
 
35 
 
Data Analysis 
Cell Quantification 
The quantification of cells was done by manually counting SCs (identified by co-
localized nuclei and S100 protein family fluorescence after immunostaining and imaging) in a 
given area and then extrapolating that cell number per unit area to the area of the scaffold 
surface. This was done at four identical locations on all scaffolds and total cell numbers were 
calculated as averages of the four sample counts to control for experimenter bias.  
 
Statistical Analyses 
One-way analyses of variance tests, along with Tukey’s Multiple Comparisons post-hoc 
tests, were used to analyze mean differences across all groups and the compare each separate 
group to each other separate group in in vitro cell migration and in vivo SCI model experiments. 
Two-way repeated measures analyses of variance tests, along with pairwise Holm-Sidak Multiple 
Comparison post-hoc tests, were used to determine the effect of different treatments at different 
time-points. Means were expressed alongside standard deviations or standard errors of mean, as 
specified in each instance. Also, Spearman correlational analyses were performed to identify the 
relationship between two functional measures across all treatment groups. 
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Figure 1.1 Air-gap electrospun product. View of the electrospinning polydioxanone cylindrical 
product (~3.0mm long) on the collecting apparatus. This represents a point about halfway 
through the construction process. In the back of the photo is the needle from which the material 
is being extruded. 
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Figure 1.2 The exposed rat spinal cord before transection and after implantation. (a) View 
of the dura-encased, exposed rat spinal cord before a complete transection. (b) View of the 
implanted 1mm-thick cylindrical scaffold held in place the pressure of the two stumps rostral and 
caudal to the transection site. The black arrow indicates this implanted scaffold (between the two 
white cord stumps). 
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Rating Description of Locomotion 
0 No observable hindlimb (HL) movement 
1 Slight movement of one or two joints (usually hip &/or knee). 
2 
Extensive movement of one joint  
or  
Extensive movement of one joint and slight movement of one other joint. 
3 Extensive movement of two joints. 
4 Slight movement of all three joints of the HL. 
5 Slight movement of two joints and extensive movement of the third. 
6 Extensive movement of two joints and slight movement of the third. 
7 Extensive movement of all three joints of the HL. 
8 
Sweeping with no weight support  
or  
Plantar placement of the paw with no weight support. 
9 
Plantar placement of the paw with weight support in stance only (i.e. when stationary)  
or  
Occasional, Frequent or Consistent weight supported dorsal stepping and no plantar 
stepping. 
10 Occasional weight supported plantar steps, no FL-HL coordination. 
11 Frequent to consistent weight supported plantar steps and no FL-HL coordination. 
12 Frequent to consistent weight supported plantar steps and occasional FL-HL 
coordination. 
13 Frequent to consistent weight supported plantar steps and frequent FL-HL 
coordination. 
14 
Consistent weight supported plantar steps, consistent FL-HL coordination; and  
Predominant paw position during locomotion is rotated (internally or externally) when 
it makes  
initial contact with the surface as well as just before it is lifted off at the end of stance  
or  
Frequent plantar stepping, consistent FL-HL coordination and occasional dorsal 
stepping. 
15 
Consistent plantar stepping and Consistent FL-HL coordination; and  
No toe clearance or occasional toe clearance during forward limb advancement,  
Predominant paw position is parallel to the body at initial contact. 
16 
Consistent plantar stepping and Consistent FL-HL coordination during gait; and  
Toe clearance occurs frequently during forward limb advancement  
Predominant paw position is parallel at initial contact and rotated at lift off 
17 
Consistent plantar stepping and Consistent FL-HL coordination during gait; and  
Toe clearance occurs frequently during forward limb advancement,  
Predominant paw position is parallel at initial contact and lift off. 
18 
Consistent plantar stepping and Consistent FL-HL coordination during gait; and  
Toe clearance occurs consistently during forward limb advancement,  
Predominant paw position is parallel at initial contact and rotated at lift off 
19 
Consistent plantar stepping and Consistent FL-HL coordination during gait; and  
Toe clearance occurs frequently during forward limb advancement.  
Predominant paw position is parallel at initial contact and lift off and  
Tail is down part or all of the time. 
20 
Consistent plantar stepping and Consistent coordinated gait;  
Consistent toe clearance  
Predominant paw position is parallel at initial contact and lift off; and  
Trunk instability, tail consistently up. 
21 
Consistent plantar stepping and Coordinated gait, consistent toe clearance,  
Predominant paw position is parallel throughout stance, consistent trunk stability and  
Tail consistently up. 
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Figure 1.3 The Basso, Beattie, Bresnahan (BBB) locomotor rating scale. The 22-point scale 
used to score locomotor function in an open-field (Basso, Beattie, and Bresnahan, 1995). 
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Figure 1.4 The open-field to obtain locomotor scale scores. The radius of the circular open-
field used to test locomotor activity was about 38 cm. Rats were allowed to freely roam this 
space for 3 minutes while two observers watched for parameters defined by the BBB Locomotor 
Scale. 
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RESULTS 
 
SC Surface-Attachment onto 3D Scaffolds was Substantial, However SC Dispersion Was 
Limited 
Air-gap electrospun, 1 mm-thick scaffolds, that underwent an identical seeding procedure 
to those that were implanted into animals, were evaluated for their ability to house cells on their 
surface in terms of the percent of cells that were initially seeded onto the surface. Of the number 
of cells that were initially seeded, 63.036% were present after a 5-day CO2 incubation (mean 
(SD) = 46,836 (3,983), N
 
= 2) (Figure 2.1a-b; Figure 2.2a-d).  
In characterizing dispersion through air-gap electrospun PDS scaffolds, we found an 
average of 75.128% (mean (SD) = 131,474 (30,044), N=3) of initially seeded cells to be present 
on the scaffold surface, 37.461% (mean (SD) = 65,556 (16,908), N=3) of seeded cells to be 
present at a 250 µm depth into the scaffold, and 3.902% (mean (SD) = 6,828 (6,002), N=3) to be 
present at a depth of 500 µm into the scaffold. All cell counts were obtained from cell-seeded 
scaffolds that had been fixed 5 days post-seeding in 4% paraformaldehyde (Figure 2.3; Figure 
2.4a-b). A comparison of the difference in cell numbers at the surface, 250 µm into the scaffold, 
and 500 µm into the scaffold revealed ample mean differences (p<0.001 [p=0.0009], df = 2, r2 = 
0.9050). Post-hoc analyses show that these large differences were evident not only across all 
groups, but between each pair of groups as well (Surface vs. 250 µm (p<0.05), Surface vs. 500 
µm (p<0.001), and 500 µm vs. 250 µm (p<0.05)). 
 
MatrigelTM, Slightly More Than Laminin, Facilitated 2D Cell Dispersion 
MatrigelTM-, laminin-, and TBS (control)-coated 5 mm x 5 mm traditionally electrospun 
scaffolds were assessed for their ability to facilitate two-dimensional SC dispersion. Cells on 
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MatrigelTM-coated scaffolds migrated over mean areas (SEMs) 2.341 (0.09185) times, 3.154 
(0.1018) times, and 4.050 (0.1689) times as expansive as the area covered by initially seeded 
cells (at Time (T) = 0 days) at 3, 5, and 7 days post-seeding, respectively. Likewise, cells on 
laminin-coated scaffolds migrated over areas 1.656 (.07490) times, 2.188 (0.04527) times, and 
2.867 (0.01789) times that of initially seeded cells, at 3, 5, and 7 days, respectively. These were 
compared to each other and to a control (a TBS-coated scaffold), which yielded cell dispersion 
1.284 (0.04440)x, 1.787 (0.1733)x, and 2.420 (0.1517)x, that of the T = 0 cell area at 3, 5, and 7 
days post-seeding, respectively. Though there was no difference (p = 0.3440, df = 2, r2 = 0.2111) 
between means of cell-covered areas of MatrigelTM-coated, laminin-coated, and TBS-coated 
scaffolds (Figure 2.5a-f). There was, however, a clear trend of cells covering increasingly greater 
areas on MatrigelTM-coated than on laminin-coated scaffolds and on laminin-coated than on 
TBS-coated scaffolds. 
 
Animals 
Animal responses to the complete transection surgery were consistent in the following 
general features. All rats lost 10-30% of their pre-surgery body weight within 7 days of the 
surgical procedure. Also, all rats became bloated within 10 hours of the surgery, due to 
distending, unrelieved bladders due to the loss of micturition control. As expected, all rats also 
lost all sensory perception and motor control caudal of the transection site. There were also 
several variable factors among the rats. About one-third of the rats performed some degree of 
self-mutilation at the level of the skin (i.e. attempting to chew through its own dermal layers) in 
the area of the peritoneum. Others developed short-term urinary tract infections, identified by 
putrid-smelling, brown-colored urine. Throughout the course of the study, two rats were 
euthanized due to extensive self-mutilation, while one died of an unknown cause. 
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SC-Seeded Electrospun PDS Bridges Affect Animal Body Weight Restoration after SCI  
All experimental in-vivo groups were evaluated for their differences in ability to restore 
lost animal body weight after a complete spinal cord transection (the control bridge group was 
excluded due to low sample size and evidence for surgical error). When compared to every other 
group, animals that received implants of SC bridges (both sides) regained a higher percentage of 
their pre-surgery body weight (p<0.0001, df = 4, r2 = 0.1742). Interestingly, post-hoc analyses 
showed that this group showed larger mean differences when compared to animals with 
caudally-facing bridges (p<0.0001) and MatrigelTM-only bridges (p<0.0001) than when 
compared to animals with rostrally-facing bridges (p<0.001) (Figure 2.7). As confirmed by the 
figure, no other groups differed from each other. 
 
SC-Seeded Electrospun PDS Bridges Do Not Affect Retained Urine Volumes after SCI 
Experimental in-vivo groups were assessed for differences in overall bladder function 
restoration as well as time taken to achieve this restoration (the control bridge group was 
excluded due to low sample size and evidence for surgical error). Means of retained urine 
volumes between groups were not found to be different (p<0.4525, df = 4, r2 = 0.06133) (Figure 
2.8). Analyses of the number of days until active micturition or until achieving a retained urine 
volume of zero also yielded no differences between groups (p<0.2149, df = 4, r2 = 0.3614) 
(Figure 2.9). However, results yield a trend for animals with SC bridges (both sides) to have 
regained micturition control over a shorter time period than scaffolds with rostrally- and 
caudally-facing SC bridges. Additionally, animal groups with both rostrally- and caudally-facing 
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SC bridges regained this control over a shorter time period than did animals with MatrigelTM-
only bridges (Figure 2.9). 
 
SC-Seeded Electrospun PDS Scaffolds and MatrigelTM-Coated Scaffolds Effect the Gain of 
Locomotor Function after SCI 
Groups were then compared to evaluate differences in the regain of locomotor function, 
as measured by the BBB scale. In comparing treatment groups, between-group mean differences 
were revealed (p<0.0001, df = 4, r2 = 0.3390). Specifically, differences were found between 
animals with SC bridges (both sides) and with control bridges (p<0.0001), between animals with 
SC bridges (both sides) and with rostrally-facing SC bridges (p<0.01), and between animals with 
MatrigelTM-only bridges and with control bridges (p<0.01) (Figure 2.10). Analyzing the effect of 
treatment groups across time, we found no difference until post-surgical day 28, at which point 
differences were first seen between the SC bridge (both sides) and the control bridge groups 
(p<0.01) and continued in these groups until the final time-point of 44 days (p<0.001 at 32 days 
onwards). At 32 days, differences were also seen between SC bridge (both sides) and rostrally-
facing SC bridge animals (p<0.05) as well as SC bridge (both sides) and MatrigelTM-only bridge 
animals (p<0.05). These differences increased from 36 to 44 days (p<0.001). At day 36, 
differences were also seen between SC bridge (both sides) and caudally-facing SC bridge 
animals (p<0.001). Differences appeared between control bridge and rostrally-facing SC bridge 
groups (p<0.05), rostrally-facing and caudally-facing SC bridge groups (p<0.05), and 
MatrigelTM-only and caudally-facing SC bridge groups (p<0.05) at 40 days and became more 
pronounced (p<0.01, p<0.001, p<0.01, respectively) at 44 days. At 44 days, differences between 
control bridge and MatrigelTM-only groups appeared (p<0.05). 
48 
 
Body Weight Restoration is Related to Functional Locomotor Activity Restoration 
Since only the rats with SC bridges (both sides) displayed differences in more than one 
assessment (body weight restoration and locomotor function recovery), this group was used to 
determine the degree of co-variation between locomotor (BBB) scale scores and percent of initial 
body weight lost over time. We found that the percent of initial body weight lost was, indeed, 
negatively-correlated with BBB scores (Pearson r = -0.6496, p = 0.0222 [p<0.05], r2 = 0.4220) 
(Figure 2.11). 
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Figure 2.1 Images of SCs attached to the surface of the 1mm-thick cylindrical electrospun 
polydioxanone scaffold. (a) Scanning electron microscopy was used to image the exterior of 
cells atop electrospun scaffolds after five days of incubation post-cell-seeding. Scaffold and cells 
were fixed in 4% paraformaldehyde, dried, gold-sputtered, and then imaged. (b) Confocal laser 
scanning microscopy was used to image fluorescently stained protein S100 (for SCs) (red) and 
nuclei (blue). The overlapping of the co-stain thus results in a purple- or pink-like color. Cells are 
atop electrospun scaffolds on which they incubated for five days post-cell-seeding before being 
fixed in 4% paraformaldehyde and then stored in 1X PBS until imaged. 
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(a)                                                                          (b) 
  
 
(c)                                                                          (d) 
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Figure 2.2 Scanning electron microscopy photographs of electrospun scaffold surfaces with 
and without attached SCs. (a) Air-gap electrospun scaffold sliced into a 1 mm-thick cylindrical 
piece. Fibers can be seen pointing straight up at the observer, and are arguably partially aligned 
(b) As in panel (a), an air-gap electrospun scaffold sliced into a 1 mm-thick cylindrical piece is 
seen, however much of the shown surface is covered in a thick cell layer, formed after five days 
of incubation post-seeding. Cell can be seen growing out from the cell layer. (c) A 
characterization of a whole scaffold, which an outer layer pulled away from the core scaffold 
piece to show its layer-like construct. As can be seen, the scaffold is diversely constructed in 
different areas. (d) As in panel (b), a thick cell layer, or a culmination of many cell layers, can be 
seen covering a large percentage of the scaffold surface. 
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Figure 2.3 The migration/infiltration of cells into a 3D scaffold. Scaffold were 
immunostained, sliced, via cryostat, and imaged, via confocal laser scanning microscopy, at the 
surface, at a depth of 250 µm into the scaffold, and at a depth of 500 µm into the scaffold. These 
are the extrapolated cell counts calculated from fluorescent images of smaller areas on the 
scaffolds (N=3) 
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Figure 2.4 Scanning electron microscopy photographs of electrospun scaffolds with and 
without cells. (a) Cells have formed a thick layer atop of the scaffold, signifying robust growth 
at the surface. Cells seem to be beginning to infiltrate the scaffold, but mainly remaining on the 
surface. (b) A similar view of a scaffold without cells is displayed to compare with the cell-
seeded scaffold to positively and reliably distinguish scaffold material from cells.  
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         Control (TBS)                               (+) Laminin                                (+) Matrigel 
(a)                                                 (e)                                                (i)                                    
                    
T=            0 days                                           0 days                                           0 days 
(b)                                                 (f)                                                (j)                                    
                                                 
T=            3 days                                           3 days                                           3 days 
(c)                                                 (g)                                                (k)                                    
                    
T=            5 days                                           5 days                                           5 days 
(d)                                                 (h)                                                (l)                                    
                   
T=            7 days                                           7 days                                           7 days 
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Figure 2.5 Fluorescent images of SC cell nuclei for cells progressively migrating in two 
dimensions over time and on different substrates. Cell-containing areas are outlined in 
white. SC dispersion on a TBS (control)-coated scaffold at (a) 3 hours post-seeding (T=0), (b) 3 
days post-seeding, (c) 5 days post-seeding, and (d) 7 days post-seeding. SC dispersion on a 
laminin-coated scaffold at T= (e) 0 days, (f) 3 days, (g) 5 days, and (h) 7 days. SC dispersion on 
a Matrigel-coated scaffold at T= (i) 0 days, (j) 3 days, (k) 5 days, and (l) 7 days. 
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Figure 2.6 Areas of 2D cell dispersion over MatrigelTM-, laminin-, and TBS-coated scaffolds 
at 0, 3, 5, and 7 days post-seeding. Data points are expressed as a multiple of the initially-
seeded (T=0). Areas are shown as means and standard deviations (shown via error bars) (N=4 at 
every time point for MatrigelTM- and laminin-coated scaffolds; N=2 at every time point for TBS-
coated scaffolds). 
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Figure 2.7 Graph of the percent of initial body weight lost in rats after SCI. Data points are 
expressed at means and standard deviations (shown via error bars) (N=4). +++ significantly 
different from bridge + MatrigelTM + SCs (Caud), p<0.0001. *** significantly different from 
bridge + MatrigelTM, p<0.0001. ^^ significantly different from bridge + MatrigelTM + SCs (Rost), 
p<0.001. 
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Fig 2.8 Graph of the amount of retained urine over time in rats after SCI. Data points are 
expressed as means and standard deviations (shown via error bars) (N=4). Groups means showed 
no significant differences. Data points without standard error of means represent only one 
animal. 
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Fig 2.9 Graph of the amount time for each treatment group to return to a state of normal 
urine retention . Data points are expressed as means and standard deviations (shown via error 
bars) (N=4). Groups means showed no significant difference. 
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Fig 2.10 Graph of BBB locomotor scale scores over time in rats after SCI. Data points are 
expressed as means and standard deviations (shown via error bars) (N=4). Groups means showed 
no significant difference. ### significantly different from bridge only, p<0.0001. # significantly 
different bridge only, p<0.05. ^ significantly different from bridge + MatrigelTM + SCs (Rost), 
p<0.05. 
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Fig 2.11 Graphs showing the co-variation (or correlation) between locomotor (BBB) scale 
score and percent of initial body weight lost for the SC bridges (both sides) treatment 
group. Data points are expressed as means and standard deviations (N=4) (a) BBB scores and 
percent of initial body weights of rats presented on the same scale and axis over time. (b) A 
correlational graph analysis of the two variables. BBB Score and percent of initial body weight 
lost were significantly correlated, p<0.0001. 
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DISCUSSION 
 
The goals of the experiments detailed in this paper were to evaluate 3D cell migration 
into electrospun polydioxanone scaffolds and to improve 2D cell dispersion across the same 
substrate. We also aimed to improve functional recovery, as measured by the return of locomotor 
activity, micturition control, and body weight, in rat models of completely transected spinal 
cords, via the implantation of SC-seeded polydioxanone electrospun scaffolds. As noted by 
Kubinova & Sykova (2012), one of the more significant advantages of a complete transection 
model is that it allows experimenters to distinguish between true axonal regeneration and 
improved functional behavior due to the collateralization of intact axons. 
 
Evaluating the Extent of 3D SC Migration 
First, we characterized 3D SC migration via immunostaining and cell-counting at 
different depths throughout an SC-seeded scaffold. Though a substantial percent of the number 
of initially-seeded cells were present on the scaffold surface five days after seeding cells onto 
one side of 1mm-thick sliced electrospun scaffolds, markedly fewer cells were found at 250 µm, 
and even fewer, significantly, at 500 µm, into the scaffold. Thus, a significant amount of attached 
cells remained at the scaffold surface or within the first 250 µm, while a few migrated to 250 
µm, and a significantly smaller portion migrated to 500 µm, arguing for the inefficacy of 3D cell 
migration in these experiments. Work by other groups have reported similar findings, for 
example, in aligned, 1 mm-thick electrospun PCL meshes, human and bovine meniscus 
fibrochondrocytes infiltrated, at best, two-thirds of the full 1mm distance after ten weeks (Baker 
et al., 2008; Baker et al., 2009). Previous studies concede that a primary limitation of electrospun 
scaffolds is their inability to facilitate infiltration, or 3D migration, alleging that their tightly 
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packed conformation of nanofibers (fibers with diameters on a nanometer scale) allow for 
superficial cellular growth and migration, however not for migration deep within the electrospun 
construct (Blakeney et al., 2011; Phipps et al., 2012; Nerurkar et al., 2011). Cell ingress into even 
0.5 mm-thick nanofibrous scaffolds has been limited (Baker et al., 2009; Baker and Mauck, 
2007). As pointed out by Nerurkar et al. (2011), the eventual clinical application of these 
constructs will likely require them to be much thicker than 1 mm, and thus limited cell 
infiltration poses a noteworthy challenge, especially since there are even differences between in 
vitro and in vivo infiltration. Other studies have approached this challenge by increasing the 
space between fibers, decreasing fiber diameter, or a combination of the two, altering construct 
porosity and offering a less spatially obstructive path for cell migration (Phipps et al., 2012; 
Vaquette et al., 2011).  
 
Implications of MatrigelTM and Laminin in 2D SC Dispersion 
In the current study, we approached the challenge of cell dispersion outlined above at the 
2D, rather than at the 3D, level. Cell growth- and dispersion-enhancing substrates laminin and 
MatrigelTM were employed to first facilitate 2D dispersion, with the prospect of pursuing a 
similar question about migration through 3D scaffolds. Though our hypothesis that MatrigelTM 
would be more effective than laminin in facilitating 2D cell dispersion was not significantly 
supported, our data show trends that suggest that further research may yet yield results to support 
our hypothesis. The lack of significant difference in the mean areas covered by cells on 
MatrigelTM-, laminin-, and TBS-coated scaffolds is consistent with reports from other similar 
studies (Thompson, Thomas, and Metcalfe, 1993; Hoffman, Kibbey, Letterio, and Kleinman, 
1996). In fact, MatrigelTM and laminin displayed no differences from each other even when they 
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were independently found to be significantly more effective than other popularly studied 
substrates, such as fibronectin, collagen, and poly-D-lysine in supporting human embryonic stem 
cell (hESC) migration and differentiation (Ma et al., 2008). It is interesting, therefore, that, in the 
current study, MatrigelTM- and laminin-coated scaffolds did not produce results that were 
significantly different than those produced by TBS (control)-coated scaffolds. Notably, however, 
a graphical trend analysis of the three groups of coated scaffolds show that, even though the 
difference is non-significant, TBS-coated scaffolds did not facilitate dispersion as effectively as 
MatrigelTM- or laminin-coated scaffolds. Also, as can be seen in Figure 2.5,  MatrigelTM-coated 
scaffolds seemed to facilitate cell proliferation more effectively than laminin-coated scaffolds or 
TBS-coated scaffolds, resulting a cell-covered area that is markedly more dense with cells at T = 
7 days than the cell-covered area of both of the other groups at the same time point. 
 
The Improvement of Locomotor Activity 
SCs vs. MatrigelTM vs. Their Combination 
In our in vivo experiments we were able to identify between-group differences in 
functional locomotor activity recovery and in body weight recovery after post-surgery weight 
loss, but not in the restoration of control over micturition. Though a one-way ANOVA between 
groups for the recovery of functional locomotor activity yielded significance at the α = 0.0001 
level, a post-hoc Tukey’s Multiple Comparison (Tukey’s) Test revealed that only the following 
three comparisons had significant differences (presented as the more effective treatment vs. the 
less effective treatment): (1) SC bridges (both sides) vs. control bridges, (2) SC bridges (both 
sides) vs. rostrally-facing SC bridges, and (3) MatrigelTM-only bridges vs. control bridges. 
Despite these significant effects of MatrigelTM-only and the combination of MatrigelTM and SCs 
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on functional locomotor improvement, no significant differences were seen as a result of the 
independent action of SCs. This lack of significant difference could be attributed to the tendency 
of SCI treatment effects to be sub-additive (meaning when treatments are combined, the resulting 
effect is not a simple sum of their effects as independent treatments). Since MatrigelTM already 
had a significant effect in improving SCI recovery in our rat model, SCs would have had to 
produce a fully additive effect to that of MatrigelTM in order to appear significant in combination 
with MatrigelTM. Thus, SCs may still have an effect that is undetectable by a statistical test like a 
one-way ANOVA. In fact, a two-way repeated measures ANOVA test showed that all group 
comparisons except for control bridge vs. caudally-facing SC bridge groups and rostrally-facing 
SC bridge vs Matrigel-only bridge groups differed significantly by the last time-point of 44 days.  
Supporting this notion, as shown in Figure 2.10, it is graphically clear that the (+)SC and (-)SC 
groups, when compared, are different. Specifically, the SC bridge (both sides) improved SCI 
recovery more than its counterpart without SCs (MatrigelTM-only bridges), confirming the 
chance that SCs do, indeed, have an effect, albeit sub-additive and non-significant in these 
studies. Partially supporting the stated hypothesis as it relates to locomotor function, the 
combination of SCs, scaffold, and MatrigelTM produced significantly different results from the 
control bridge group (scaffold only), but not from the MatrigelTM-only group. 
 
MatrigelTM-Coated Scaffolds Alone Produce Improved Locomotion 
As hypothesized, and mentioned above, there was a marked mean difference between 
animals with SC bridges (both sides) and animals with control bridges. This finding supports the 
strongly established claim that implanted SCs, especially in the presence of MatrigelTM, promote 
locomotive function after SCI (Bunge, 2008; Oudega, 2007; Xu et al., 1995). The significant 
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difference found between animals with MatrigelTM-only bridges and animals with control bridges 
partially agrees with and partially complements findings by other groups. For example, while 
Tsai et al. (2006) shows that the total axon density within a synthetic hydrogel channel was 
significantly increased with MatrigelTM, however alleged that it did not produce improvements in 
locmotor function. Our findings show that MatrigelTM does, indeed, improve locomotor function, 
supporting its wide use in the application of SCs, and other cell types, to improve SCI recovery 
(Fouad et al., 2005; Tsai et al., 2006; Xu et al., 1995; Xu et al., 1997). It is important to note that 
2 of the 3 animals that died were of the Matrigel-only bridge group (one died at 10 days and the 
other at 35 days). These deaths speculate upon the inadequacy of Matrigel, in addition to 
electrospun bridges, to block SCI-related mortality. 
 
Possible Error in Finding a Mean Difference Between Rostrally- vs. Caudally-Localized SCs 
The significantly larger improvement in locomotor activity in SC bridge (both sides) rats, 
when compared to rostrally-facing SC bridge rats, but not when compared to caudally-facing SC 
bridge rats, is a surprising result. This suggests that caudally-facing SC bridges improve 
functional locomotion in rats better than their rostrally-facing counterparts. Though this may be 
explained anatomically, the lack of significant improvements in locomotor function in animals 
with either rostrally- or caudally-facing SC bridges, compared to animals treated with control 
bridges, suggest that this difference may be due to statistical error, possibly because of the small 
sample size used (N=4). Further supporting this assertion, there was also no difference in the 
effect on locomotor function recovery between rostrally- and caudally-facing SC bridge groups. 
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Trend Differences in the Urine Retention 
Though there was no significant variance between groups in the retention of urine, there 
was a discernible trend. Additionally, the perceivable difference trend between groups in the 
number of days until rats yield zero retained urine volume suggests that any effect on retention 
becomes more apparent as treatments are combined (i.e. the number of days until normal urine 
retention is achieved decreases steadily from the MatrigelTM-only bridge group, to the one-side 
seeded SC bridge groups, and finally to the SC bridge (both sides) group, which displays the 
shortest average time until normal urine retention is regained). Thus, the hypothesis that the 
combination of SCs, scaffold, and MatrigelTM will restore normal urine retention more 
effectively than control bridge or MatrigelTM-only bridge groups may arguably, though non-
significantly, be supported.  
 
Combinatorial Approaches Effectively Occurred Alongside Body Weight Changes 
The effect on body weight restoration of the combinatorial treatment of bridge + 
MatrigelTM + SCs on both sides (SC bridge (both sides)), when compared to body weight 
restoration as a result of all other groups, was significantly greater at least at the α = .001 level, 
thus strongly supporting the stated hypothesis and furthermore shows the power of this 
combinatorial treatment. Changes in body weight may represent a more comprehensive recovery 
after SCI, since so many physiological factors contribute to body weight management. 
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Confirming the Combinatorial Treatment’s Effect in on Body Weight and Locomotor 
Activity Restoration 
Since the animals with SC bridges (both sides) showed significantly more effect, when at 
least compared to the bridge control group, in the restoration of body weight and locomotor 
activity, a correlational analysis was performed between body weight changes and locomotor 
function improvements in animals with SC bridges (both sides). The demonstration that these 
two measures are highly correlated suggests that any experimental group that displays highly 
significant differences from other groups in one measure should also do so in the other measure. 
This held true with the SC bridge (both sides) group of rats, importantly strengthening the claim 
of their significance, considering the small sample sizes analyzed. This significant correlation 
also argues for possible similar homeostatic mechanisms for locomotor control and weight 
management. 
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CONCLUSION 
The current study found that 3D SC migration is highly limited and that 2D dispersion may be 
further facilitated by MatrigelTM or laminin. Though, the hypothesis that MatrigelTM would be 
more effective than laminin in facilitating 2D SC dispersion was not significantly supported. 
Bridges with MatrigelTM and SCs (on both sides of the scaffold) were found to be significantly 
better when compared to control bridges, in improving locomotor activity, and when compared 
to all other treatments, in restoring body weight after SCI-induced weight loss. This supports our 
previously stated hypothesis that the combination would be effective; only trending differences 
were found between groups in their effect on retained urine volumes, thus the hypothesis about 
the treatment combination’s ability to significantly affect the restoration of micturition control 
was not supported . A correlational analysis further established the significance of the effects of a 
fully combinatorial treatment (SCs + scaffold + MatrigelTM). This study showed that the 
particular combination of SCs, electrospun scaffold, and MatrigelTM successfully facilitated the 
substantial attachment of SCs to the scaffold surface. We also demonstrated that once implanted 
as a bridge, this combination successfully improved functional recovery, as measured by body 
weight restoration and improvements in locomotor activity, after SCI in rats. More work is 
needed to optimize 2D and 3D SC migration into scaffolds to be implanted into SCI sites, which 
may further improve functional recovery. However, currently available evidence suggests that 
SCS, interpolated throughout the SCI site on a guidance and physical support-providing scaffold, 
may be among the most simple, yet comprehensive, approaches to improve recovery after SCI. 
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